CAJ | 학술논문

目的评价脑通治疗血管性痴呆(VD)的疗效。方法对确诊为VD患者48例，随机分成2组，服用脑通组24例，对照组24例，根据简易精神状态检查表(MMSE)总分及定向力、记忆力、语言、回忆、注意力及计算力 5个因子分评定疗效。结果脑通组 2周疗效略优于对照组；MMSE总分值大于对照组，治疗8周后明显优于对照组，对重症痴呆患者也有一定的疗效，副作用较轻。结论脑通是治疗VD的有效药物，对各期痴呆均有疗效，而且副作用小。
목적평개뇌통치료혈관성치태(VD)적료효。방법대학진위VD환자48례，수궤분성2조，복용뇌통조24례，대조조24례，근거간역정신상태검사표(MMSE)총분급정향력、기억력、어언、회억、주의력급계산력 5개인자분평정료효。결과뇌통조 2주료효략우우대조조；MMSE총분치대우대조조，치료8주후명현우우대조조，대중증치태환자야유일정적료효，부작용교경。결론뇌통시치료VD적유효약물，대각기치태균유료효，이차부작용소。
Objective To study the therapeutic effect of Sermion on vascular dementia(VD) . Method 48 VD patients were randomly divieded into Sermion group and control group. Effects and side - reaction were evaluated by (MMSE), clinical fourdegree sale . Result Sennion group has a some response about 2 weeks and better anti - dementia effects than control group within treatment period of 2 ～ 8 weeks,good for severe dementia. Conclusion To obtain a better effects with Sermion comparing to control group 2 ～ 8 weeks after treatment of VD.